迈瑞医疗收盘上涨1.09%，滚动市盈率25.12倍，总市值2798.19亿元

Core Viewpoint - Mindray Medical's stock closed at 230.79 yuan, with a rolling PE ratio of 25.12 times, and a total market capitalization of 279.82 billion yuan, indicating a relatively lower valuation compared to the industry average [1] Company Summary - Mindray Medical's main business includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - For Q1 2025, the company reported revenue of 8.24 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.63 billion yuan, down 16.81%, with a gross profit margin of 62.53% [1] Industry Summary - The average PE ratio for the medical device industry is 54.79 times, with a median of 37.86 times, positioning Mindray Medical at the 51st rank within the industry [2] - The total number of shareholders for Mindray Medical as of March 31, 2025, is 92,191, an increase of 9,446 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]